Kevin R. Lind

2021 - Longboard Pharmaceuticals

In 2021, Kevin R. Lind earned a total compensation of $875.1K as President and Chief Executive Officer at Longboard Pharmaceuticals, a 62% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$316,726
Salary$546,616
Other$11,792
Total$875,134

Lind received $546.6K in salary, accounting for 62% of the total pay in 2021.

Lind also received $316.7K in non-equity incentive plan and $11.8K in other compensation.

Rankings

In 2021, Kevin R. Lind's compensation ranked 9,206th out of 12,415 executives tracked by ExecPay. In other words, Lind earned more than 25.8% of executives.

ClassificationRankingPercentile
All
9,206
out of 12,415
26th
Division
Manufacturing
4,086
out of 5,505
26th
Major group
Chemicals And Allied Products
1,802
out of 2,375
24th
Industry group
Drugs
1,602
out of 2,096
24th
Industry
Pharmaceutical Preparations
1,189
out of 1,546
23rd
Source: SEC filing on April 13, 2022.

Lind's colleagues

We found two more compensation records of executives who worked with Kevin R. Lind at Longboard Pharmaceuticals in 2021.

2021

Brandi Roberts

Longboard Pharmaceuticals

Chief Financial Officer

2021

Philip Perera

Longboard Pharmaceuticals

Chief Medical Officer

News

You may also like